0000919574-20-004430.txt : 20200702 0000919574-20-004430.hdr.sgml : 20200702 20200702164819 ACCESSION NUMBER: 0000919574-20-004430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200701 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners Master Fund, L.P. CENTRAL INDEX KEY: 0001534265 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 201010261 BUSINESS ADDRESS: STREET 1: WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Capital, LLC CENTRAL INDEX KEY: 0001534261 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 201010262 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 2600 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Partners GP, LLC CENTRAL INDEX KEY: 0001534260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 201010263 BUSINESS ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.300.5575 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casdin Eli CENTRAL INDEX KEY: 0001534264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 201010264 MAIL ADDRESS: STREET 1: 1350 AVENUE OF THE AMERICAS STREET 2: SUITE 1140 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2020-07-01 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001534265 Casdin Partners Master Fund, L.P. 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 0 0 1 0 0001534261 Casdin Capital, LLC 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 0 0 1 0 0001534260 Casdin Partners GP, LLC 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 0 0 1 0 0001534264 Casdin Eli 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 0 0 1 0 Common Stock, par value $.001 per share 2020-07-01 4 P 0 685000 14.50 A 5534524 D Common Stock, par value $.001 per share 2020-07-02 4 P 0 305583 14.50 A 5840107 D The reported securities were purchased by Casdin Partners Master Fund, L.P. (the "Master Fund") in a private investment in public equity transaction with the issuer on July 1, 2020. The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. On July 2, 2020, the Master Fund entered into a stock purchase agreement with a director of the issuer pursuant to which the Master Fund agreed to purchase the reported securities from such director for a purchase price equal to $14.50 per common stock. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Casdin Partners Master Fund LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member 2020-07-02 Casdin Capital, LLC, By: /s/ Eli Casdin, Managing Member 2020-07-02 Casdin Partners GP LLC, By: /s/ Eli Casdin, Managing Member 2020-07-02 /s/ Eli Casdin 2020-07-02